Cenomar

Cenomar is a pharmaceutical product containing Levofloxacin, used for various bacterial infections. This intravenous medication is manufactured by Stada Arzneimittel AG and is suitable for EU markets.

Cenomar, containing Levofloxacin, is commonly used to treat a range of bacterial infections. It is often prescribed for conditions such as respiratory tract infections, urinary tract infections, and skin infections. Levofloxacin works by stopping the growth of bacteria, helping the body to fight off infections effectively. Patients may wonder, 'What is Cenomar used for?' and the answer lies in its broad-spectrum antibacterial properties.

When administered intravenously, Cenomar may cause common effects such as nausea, diarrhea, and headache. Some patients might experience dizziness or insomnia. It is important to monitor for any unusual symptoms and consult a healthcare provider if severe side effects occur.

Cenomar should be used with caution in patients with a history of seizures, tendon problems, or myasthenia gravis. It is essential to inform your healthcare provider about any existing medical conditions or allergies before starting treatment. Proper storage and handling are crucial to maintain the effectiveness of the medication.

Cenomar may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), anticoagulants, and other antibiotics. It is advisable to avoid alcohol while taking Levofloxacin, as it may increase the risk of side effects. Always consult a healthcare provider before combining Cenomar with other medications.